From: Effect of delayed misoprostol dosing interval for induction of labor: a retrospective study
Demographics | Routine Interval Dosing, n = 64 | Delayed Interval Dosing, n = 69 |
---|---|---|
Maternal Age, Yr | 30.5 (+/− 7.06) | 29.9 (+/− 6.3) |
Maternal BMI, kg/m2 | 33.7 (+/− 8.02) | 35.3 (+/− 7.35) |
Gestational Age, weeks | 39 + .73 days (+/−14.29 D) | 38 + 5.9 days (+/− 15.5 D) |
Median Starting Bishop Score | 3 | 2 |
White (Non Hispanic) | 98.44% | 95.7% |
Non-smoker | 87.50% | 91.3% |
Drug Use | 7.8% | 4.3% |
Prior Vaginal Delivery | 50%* | 31.9%* |
Oxytocin Administration | 71% | 71% |
Induction Indications | ||
Hypertensive Disorder | 32.81% | 39.1% |
Late Term Gestation | 31.25% | 24.6% |
AMA | 6.25% | 4.3% |
Diabetes | 7.81% | 8.7% |
Cholestasis | 1.56% | 4.3% |
IUGR | 7.81% | 7.2% |
Oligohydramnios | 1.56% | 4.3% |
Other | 10.94% | 5.7% |
Unstable Lie | 0 | 1.4% |